STAAR Surgical Company
STAA
$25.26
-$0.61-2.36%
NASDAQ
| 06/27/2025 | 03/28/2025 | 12/27/2024 | 09/27/2024 | 06/28/2024 | |
|---|---|---|---|---|---|
| Net Income | 68.99% | -58.38% | -442.97% | 35.25% | 320.99% |
| Total Depreciation and Amortization | -15.49% | -1.60% | 35.17% | 15.44% | 23.04% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -79.36% | 142.00% | -33.31% | -12.09% | 69.46% |
| Change in Net Operating Assets | -153.96% | 14.95% | 239.84% | 41.21% | -284.95% |
| Cash from Operations | -375.22% | -993.15% | -83.18% | 136.65% | -148.03% |
| Capital Expenditure | -22.07% | 74.36% | 8.12% | 0.08% | -19.88% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -26.91% | 367.39% | 52.53% | -101.01% | -167.47% |
| Cash from Investing | -28.94% | 281.33% | 44.68% | -70.51% | -227.68% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 100.00% | -2.44% | 2.38% | 0.00% | -5.00% |
| Issuance of Common Stock | -96.82% | 842.50% | -97.59% | 345.43% | -93.01% |
| Repurchase of Common Stock | -254.79% | -1,077.06% | -- | 100.00% | 86.41% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -378.90% | -761.82% | -106.81% | 890.80% | -95.98% |
| Foreign Exchange rate Adjustments | 139.86% | 132.46% | -184.96% | 414.24% | 64.78% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -120.66% | 245.91% | 31.03% | 7.92% | -176.24% |